CF
LEGN icon

Corebridge Financial’s Legend Biotech LEGN Stock Holding History

Corebridge Financial’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-740
Closed -$25.1K – 1508
2025
Q1 		$25.1K Hold
740
– – ﹤0.01% 2869
2024
Q4 		$24.1K Hold
740
– – ﹤0.01% 2944
2024
Q3 		$36.1K Sell
740
-160
-18% -$8.52K ﹤0.01% 2928
2024
Q2 		$39.9K Buy
+900
New +$41.5K ﹤0.01% 2930

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Corebridge Financial's LEGN Position: Q2 2025 in Review

Corebridge Financial sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 740 shares — an estimated $25.1K sold.

Corebridge Financial first reported a position in LEGN in Q2 2024 and held it in 4 quarters. The position peaked at $39.9K in Q2 2024. 211 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • Corebridge Financial reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 740 Legend Biotech shares in Q2 2025, an estimated $25.1K.
  • Corebridge Financial first reported a position in Legend Biotech in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Legend Biotech position peaked at $39.9K in Q2 2024.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.